Q. Should we treat all breast cancer aggressively, just to be safe?
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A. All patients don’t need all treatments. As our knowledge and understanding of outcomes has improved, we can safely personalize care. Using evidence-based management practices, we often are able to provide the best results with less treatment and minimal side effects.
Studies have shown that some patients over age 65 with early-stage breast cancer may be safely managed with surgery alone and may not need chemotherapy or radiation. In fact, radiation has not been shown to improve long-term survival in these patients
Similarly, chemotherapy is no longer prescribed for certain stages and types of breast cancer. We use molecular tests to determine which patients will and won’t benefit from chemotherapy.
For some patients when radiation is warranted, a single dose of intraoperative radiation can lower recurrence risk in a cost-effective way without causing side effects.
Because prognostic information based on molecular type allows us to personalize care, we engage patients in discussions of benefit and risk. They need to know that aggressive treatment may not always mean better outcomes.
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust